about
The kinase inhibitor imatinib mesylate inhibits TNF-{alpha} production in vitro and prevents TNF-dependent acute hepatic inflammationAging of the male reproductive system.CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice.Regulatory T cells in cancer biology: a possible new target for biochemical therapies.The kinase inhibitor imatinib--an immunosuppressive drug?Molecular pathogenesis of Philadelphia-positive chronic myeloid leukemia - is it all BCR-ABL?Ovarian cancer stem cells.Proliferative disorders of the aging human prostate: involvement of protein hormones and their receptors.siRNA-mediated knock-down of P-glycoprotein expression reveals distinct cellular disposition of anticancer tyrosine kinases inhibitors.Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancer.Cystatin C and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis.CD34+/CD133- circulating endothelial precursor cells (CEP): characterization, senescence and in vivo application.RNAi-mediated knockdown of P-glycoprotein using a transposon-based vector system durably restores imatinib sensitivity in imatinib-resistant CML cell lines.Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes.An unusual member of the human growth hormone/placental lactogen (GH/PL) family, the testicular alternative splicing variant hPL-A2: recombinant expression revealed a membrane-associated growth factor molecule.TGF-beta cytokines increase senescence-associated beta-galactosidase activity in human prostate basal cells by supporting differentiation processes, but not cellular senescence.Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia.A low-molecular-weight fraction of human seminal plasma activates adenylyl cyclase and induces caspase 3-independent apoptosis in prostatic epithelial cells by decreasing mitochondrial potential and Bcl-2/Bax ratio.Seminal plasma factors induce in vitro PRL secretion in smooth muscle cells of the human prostate.Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease.[Complete remission of an idiopathic hypereosinophilic syndrome while using imatinib].The role of P-glycoprotein in imatinib resistance.MicroRNAs and their role for T stage determination and lymph node metastasis in early colon carcinoma.Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T-cells is preserved in cancer patients.Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation.The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice.Autocrine formation of hepcidin induces iron retention in human monocytesHigh levels of zinc ions induce loss of mitochondrial potential and degradation of antiapoptotic Bcl-2 protein in in vitro cultivated human prostate epithelial cellsThe development of benign prostatic hyperplasia by trans-differentiation of prostatic stromal cellsResistance reversal by RNAi silencing of MDR1 in CML cells associated with increase in imatinib intracellular levelsThe effect of zoledronic acid on the function and differentiation of myeloid cellsThe effect of IgVH mutational status on the induction of apoptosis by rituximab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: evidence from a clinical phase I/II trialKnockdown of PgP resensitizes leukemic cells to proteasome inhibitorsRole of forkhead box protein 3 expression in invasive breast cancerRe: Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agentsLetters regarding article by Wojakowski et al, "mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infaSpecial edition myeloproliferative neoplasia - disease pathogenesis and treatment optionsElevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematologyHigh IL-12 p35 and IL-23 p19 mRNA expression is associated with superior outcome in ovarian cancer
P50
Q34015801-085223D4-936E-472F-BBA5-063A237A7ECAQ34102944-C511D918-5651-4FDB-879D-8273DE61361EQ34556196-9082F89F-0909-440D-AEE7-C0C143BC815BQ36486284-86D3AF08-3B88-4E64-89E6-D673CAFE0613Q36822587-5EAC7270-AF72-4326-A0D8-62FE54ABD885Q37808237-1767DB63-4498-4C29-86D9-1988018F6C13Q38031960-E90E3031-8460-46A2-8200-4655BB47AC34Q38323914-A493D287-DC24-4E9C-AEC4-00B904504BC6Q39707061-51422954-4775-478B-A315-CC0C88471BE8Q39890756-E03F70F3-B371-492A-B5F7-AE8D327DB1D8Q39901357-CA0158BF-3BB8-4055-8218-E4A45A3DCE58Q40280361-EB397B06-79BD-43F3-99FF-0C4BD772EFF2Q40407931-D821A802-EB77-4C69-B87A-A36A1EA9EC00Q40515404-8B862D83-E542-4E58-9D11-EF1B8220DE8CQ40853133-77B613AA-1FA7-4504-9799-4290183FCA90Q42451907-DA3300AB-5EE4-4B25-A82E-3342EFDD3AB7Q42702851-E204F4F1-22EA-46B9-8572-F85ECED72922Q43548101-B60ACE2A-5FCA-4795-8364-C764634BECF3Q43794634-4B782F86-5419-4D80-B77A-A0E72D4C3A92Q45068428-3F9EBEFF-18DE-4323-84E5-A460F98CDD66Q45083909-6A60046E-689A-4D48-8D22-9D79BAFC8B7EQ46790738-FE5F4E91-A0F6-406A-ADDB-947ECD200953Q48310742-B01DBB35-6462-4EC9-A9EF-FA5908FE07E3Q53351188-FCC97B48-0E83-408B-A7F0-94086D63F368Q53557826-84AC5C37-BC1A-4AFA-AFB9-666CA443C069Q53646174-5B81DDA9-4547-46BF-85F6-96D4165350E5Q53647305-52A075B6-A5F8-4A6B-8718-5CB1A516B3BFQ58876413-217D9CC1-A7D2-4E59-B75D-370537EA4FDDQ73300092-7FB389F1-33F9-44C1-8955-A9850396BEF6Q74734223-7EF83A57-4647-4286-A472-69C45CB0B1DDQ80147873-C2A3360A-93CD-4603-9D06-76AF2C148A4AQ80222483-BC4A3B07-A5A1-4ED3-92D9-6F7426718828Q80222570-440883C5-B58E-4F86-BD5E-B5158307066CQ80699766-BC59E792-7C5C-4B4C-9C4C-5E5697480869Q81375281-3DBD3E66-93CA-40DD-87F0-DF28141977A8Q81616464-FEAD1C5A-BC15-48CE-AD93-DE0FABFE82E0Q81777586-D7CB337A-40B0-45F4-A1AD-235240BE38EEQ83352311-201D9C0C-7F19-4E87-A5C5-0DB266F567EBQ84064985-17FBDA77-1E1F-4D01-ABF8-A4C3CE5C8609Q84526014-6D51A00E-3DB5-4F1A-93EA-131C9F43AEBC
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Holger Rumpold
@ast
Holger Rumpold
@en
Holger Rumpold
@es
Holger Rumpold
@nl
Holger Rumpold
@sl
type
label
Holger Rumpold
@ast
Holger Rumpold
@en
Holger Rumpold
@es
Holger Rumpold
@nl
Holger Rumpold
@sl
prefLabel
Holger Rumpold
@ast
Holger Rumpold
@en
Holger Rumpold
@es
Holger Rumpold
@nl
Holger Rumpold
@sl
P106
P21
P31
P496
0000-0002-4118-0111